RA Capital Nexus Fund III, L.P.'s Net Worth

-$3.9 Million

Estimate Recalculated Jul 17, 2024 05:12PM EST

Who is RA Capital Nexus Fund III, L.P.?

RA Capital Nexus Fund III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Mineralys Therapeutics, Inc..

SEC CIK

RA Capital Nexus Fund III, L.P.'s CIK is 0001883840

Past Insider Trading and Trends

2023 was RA Capital Nexus Fund III, L.P.'s most active year for acquiring shares with 5 total transactions. RA Capital Nexus Fund III, L.P.'s most active month to acquire stocks was the month of January. 2023 was RA Capital Nexus Fund III, L.P.'s most active year for disposing of shares, totalling 2 transactions. RA Capital Nexus Fund III, L.P.'s most active month to dispose stocks was the month of January. 2023 saw RA Capital Nexus Fund III, L.P. paying a total of $20,000,000.00 for 3,222,476 shares, this is the most they've acquired in one year. In 2023 RA Capital Nexus Fund III, L.P. cashed out on 1,928,476 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mineralys Therapeutics, Inc. (MLYS) Snapshot price: $12.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
+127.55%
1.67M
$13.50
$22,578,858.00
2.98M
Feb 12
Form 4
∞
3.18M
$16.00
—
3.18M
Feb 14
Form 4
—
0
—
—
0
Feb 9
Form 3
—
0
—
—
0
No matching records found

Eliem Therapeutics, Inc. (ELYM) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+76.18%
18.27M
$3.84
$49,952,816.64
42.25M
Jun 27
No matching records found